About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Rheumatoid Arthritis Clinical Trials | 886 Studies Recruiting

Clinical TrialsRheumatoid Arthritis

Rheumatoid Arthritis Clinical Trials

Browse 886 clinical trials for rheumatoid arthritis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 886 trials

TerminatedSafety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)The purpose of this study is to assess the safety and efficacy of MK-8457 + Methotrexate (MTX) in participants with active rheumatoid arthritis (RA) despite MTX therapy.NCT01569152 CompletedA Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)This is an observational study designed to follow patients with RA who have had an inadequate response to one or more anti-TNF therapies and who will receive Rituxan.NCT00443443·Birmingham, Alabama and 192 others

Related Searches

Data from ClinicalTrials.govTerms

Active not recruitingAn Ascending Dose Study of PIT565 in Participants With Rheumatoid ArthritisThe purpose of the study is to determine the safety, tolerability, and pharmacokinetics of PIT565, in participants with rheumatoid arthritis (RA).NCT07029555·Pilar, Buenos Aires and 15 others

CompletedStudy of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult PatientsThe purpose of this study is to assess if Abatacept given for six months will prevent rheumatoid arthritis (RA) in patients who are at risk for the development of RA in comparison…NCT00124449·Huntsville, Alabama and 47 others

CompletedFeasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)The goal of this clinical trial is to learn if the PREVAIL model of care is a feasible way to integrate rehabilitation into routine rheumatology care for adults with rheumatoid…NCT06706999·Chapel Hill, North Carolina

CompletedCx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis PatientsPhase Ib/IIa clinical trial of a new medicinal product of the somatic cell therapy class (eASCs).NCT01663116·Mérida, Badajoz and 22 others

CompletedPhase I Clinical Study of ZL-82 TabletsZL-82 is an oral janus kinase (JAK) inhibitor. In vitro biological mass spectrometry identification test proves that ZL-82 can selectively and irreversibly inhibit JAK3.NCT06055023·Guizhou, GuiYang

CompletedOpen Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisThe study aims to evaluate the predictability of early response to Certolizumab pegol in combination with Methotrexate at one year in patients with moderate to severe rheumatoid…NCT01443364·Bari and 17 others

UnknownExpression of IRAK1 Gene rs1059703-related Single- Nucleotide Polymorphisms in Egyptian Patient With Rheumatoid ArthritisRheumatoid arthritis (RA) is known as a long-lasting inflammatory autoimmune disease affecting the diarthrodial joints, which is diagnosed by inflammation and hyperplasia in…NCT05588817·Sohag

CompletedA Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid ArthritisThis 2 arm study will investigate the effects of tocilizumab on lipids, arterial stiffness, and markers of atherogenic risk in patients with moderate to severe active rheumatoid…NCT00535782·Anniston, Alabama and 39 others

CompletedEvaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT ImagingDetermine the localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with active RA and concordance with clinical symptomology.NCT02683421·Los Angeles, California and 1 other

UnknownEffect of Baricitinib Treatment on Peripheral Bone in RAPatients with Rheumatoid Arthritis (RA) suffer systemic and peripheral bone loss.NCT03701789·Erlangen, Bavaria

UnknownPredictive Analytics for Theranosis in RARA is the most common inflammatory, persistent and progressive disease of the joints with serious co-morbidities and huge health and socio-economic impact worldwide.NCT02928276·Brussels, Bruxelles-capital and 4 others

CompletedThe Chinese University of Hong Kong Early Arthritis StudyThe purpose of this study is: 1.NCT00901550·Hong Kong and 2 others

CompletedEfficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking MethotrexateThe study compared the efficacy and assessed the safety of secukinumab given as 3 intravenous (i.v.) loading doses or weekly sub-cutaneous (s.c.) loading doses, compared to…NCT01359943·Vestavia Hills, Alabama and 38 others

CompletedStudy Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α TherapyPeople affected by rheumatoid arthritis are often suffering from fatigue and decreased QOL. In this study we are measuring the impact of SC biologics on these parameters.NCT01521884·Leuven

CompletedThe Effects of Nutritional on Disease Activity and Functional Status in RARheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disease.NCT05227885·Balıkesir

CompletedA Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsThis study aims to confirm if patients with a specific biomarker might have a better response to secukinumab treatment.NCT01426789·Phoenix, Arizona and 35 others

CompletedA Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)This is a Phase 1, pharmacokinetic and pharmacodynamic study of intravenous and subcutaneous administered golimumab in patients with rheumatoid arthritis.NCT01362153·Glendale, Arizona and 8 others

TerminatedOpen-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid ArthritisThe purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTXNCT00233558·North Chicago, Illinois

PreviousPage 5 of 45Next